Bank Hapoalim BM decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 13.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,248 shares of the healthcare conglomerate’s stock after selling 813 shares during the quarter. Bank Hapoalim BM’s holdings in UnitedHealth Group were worth $2,480,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently made changes to their positions in the company. Chelsea Counsel Co. purchased a new stake in UnitedHealth Group during the 4th quarter valued at $27,000. Freedom Wealth Alliance LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $31,000. Investors Research Corp boosted its position in shares of UnitedHealth Group by 51.1% during the fourth quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 24 shares in the last quarter. Legend Financial Advisors Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Finally, Bourgeon Capital Management LLC increased its position in UnitedHealth Group by 192.3% during the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $40,000 after buying an additional 50 shares in the last quarter. Institutional investors own 92.61% of the company’s stock.
Analyst Ratings Changes
Several analysts recently commented on the stock. Loop Capital increased their price objective on shares of UnitedHealth Group from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Monday, April 17th. StockNews.com lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Royal Bank of Canada reiterated an “outperform” rating and issued a $592.00 price objective on shares of UnitedHealth Group in a report on Monday, April 17th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of UnitedHealth Group from $627.00 to $564.00 in a report on Friday, June 16th. Finally, Raymond James restated a “strong-buy” rating and set a $630.00 price objective on shares of UnitedHealth Group in a research report on Friday, April 14th. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $590.84.
Insider Buying and Selling at UnitedHealth Group
UnitedHealth Group Stock Performance
UNH opened at $461.58 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The company has a 50 day simple moving average of $481.95 and a two-hundred day simple moving average of $487.87. The firm has a market cap of $429.74 billion, a P/E ratio of 21.11, a PEG ratio of 1.35 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH – Free Report) last announced its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, beating the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The business had revenue of $91.93 billion for the quarter, compared to the consensus estimate of $89.77 billion. During the same period in the previous year, the business earned $5.49 earnings per share. The business’s revenue was up 14.7% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 24.85 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th were issued a $1.88 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date was Thursday, June 15th. UnitedHealth Group’s payout ratio is currently 34.39%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- EV Mixed Signals: Sales Are Rising, But Inventory Slower To Move
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
